These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6323979)

  • 21. [Clinical experience with a new antihypertensive drug (captopril SQ 14.225), an oral inhibitor of converting enzyme].
    Santucci A; Aguglia F; Ficara C
    Clin Ter; 1981 Apr; 97(1):43-58. PubMed ID: 6269793
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of angiotensin converting enzyme inhibitor (SQ 14225) on renin-angiotesin sytem and haemodynamics (author's transl)].
    Shigetomi S
    Horumon To Rinsho; 1980; 28(5):531-5. PubMed ID: 6248275
    [No Abstract]   [Full Text] [Related]  

  • 23. [Captopril - profile of a new antihypertensive (author's transl)].
    Gross F
    MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current clinical use of converting enzyme inhibitors].
    Corvol P; Plouin PF; Castaigne A; Palsky E
    Rev Prat; 1982 Jan; 32(1):75-82. PubMed ID: 6275488
    [No Abstract]   [Full Text] [Related]  

  • 25. Captopril for hypertension.
    Med Lett Drugs Ther; 1980 May; 22(9):39-40. PubMed ID: 6245345
    [No Abstract]   [Full Text] [Related]  

  • 26. [Renin-angiotensin system antagonists].
    Ogawa M; Inagaki Y
    Nihon Rinsho; 1983 Dec; 41(12):2703-8. PubMed ID: 6371300
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction to the symposium on practical aspects of angiotensin-converting enzyme inhibition.
    Chilton RJ
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):164-5. PubMed ID: 3030976
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of captopril in therapeutic combinations].
    Alföldi S
    Acta Pharm Hung; 1997 Jul; 67(4):149-53. PubMed ID: 9289943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in vasodilator therapy for heart failure.
    Cohn JN
    N Engl J Med; 1980 Jun; 302(25):1414-6. PubMed ID: 6246428
    [No Abstract]   [Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibition therapy in heart failure: practical guidelines.
    DiBianco R
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):194-9. PubMed ID: 3030981
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preventive effect of captopril on the development of genetic hypertension in SHR rats (author's transl)].
    Giudicelli JF; Freslon JL; Richer C
    Nouv Presse Med; 1981 Apr; 10(19):1547-9. PubMed ID: 6269556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Captopril - a genuine innovation.
    Drug Ther Bull; 1982 Feb; 20(4):13-5. PubMed ID: 6277587
    [No Abstract]   [Full Text] [Related]  

  • 34. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Captopril.
    Ram CV
    Arch Intern Med; 1982 May; 142(5):914-6. PubMed ID: 6282230
    [No Abstract]   [Full Text] [Related]  

  • 36. Usefulness of orally active angiotensin I converting enzyme inhibitor (SQ 14,225) in the treatment of malignant hypertension.
    Abe I; Kawasaki T; Ueno M; Kawano Y; Uezono K; Ogata M; Kawazoe N; Omae T; Fukiyama K
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):157-66. PubMed ID: 6247259
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
    Levine TB; Franciosa JA; Cohn JN
    Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
    [No Abstract]   [Full Text] [Related]  

  • 38. Antihypertensive agents: a new angiotensin converting enzyme inhibitor: captopril.
    Romankiewicz JA
    J Pract Nurs; 1982 Apr; 32(4):9-11. PubMed ID: 7042961
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
    Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
    [No Abstract]   [Full Text] [Related]  

  • 40. Thou, gentle viper: an introduction.
    Zanchetti A
    Am J Cardiol; 1982 Apr; 49(6):1381-2. PubMed ID: 6280469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.